Carni Lipson Feder is an Assay Development Scientist at MeMed since May 2022. Prior to that, they worked as a Postdoctoral Fellow at Technion - Israel Institute of Technology under the Cancer Biology and Cannabinoid Research Laboratory, specializing in small molecule characterization using LC-MS. In 2006-2007, they were a Research Assistant at Tel Aviv University.
May, 2022 - present